Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD: Our Bureau, New Delhi Saturday, ...
US FDA approves Amgen’s Uplizna to treat IgG4-related disease: Thousand Oaks, California Saturday, April 5, 2025, 11:00 Hrs [IST] Amgen announced that the US Food and Drug Admin ...
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025: Basel Saturday, April 5, 2025, 10:00 Hrs [IST] Roche announced that new data were p ...
Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi: Our Bureau, Mumbai Friday, April 4, ...
Nandita Vijayasimha, Bengaluru Saturday, April 5, 2025, 08:00 Hrs [IST] ...
WB DCA files police complaint against threatening calls to DIs to stop inspections at sale premises & supply chains: Peethaambaran Kunnathoor, Chennai Saturday, April 5, 2025, 08: ...
Gireesh Babu, New Delhi Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Indian pharma poised to enhance affordability & accessibility of CAR-T cell therapy to combat cancer
Indian pharma poised to enhance affordability & accessibility of CAR-T cell therapy to combat cancer: Shardul Nautiyal, Mumbai Saturday, April 5, 2025, 08:00 Hrs [IST] The Indian ...
The Good Bug presents clinically proven natural GLP-1 weight loss solution amid rising obesity rates in India: Our Bureau, Bengaluru Friday, April 4, 2025, 17:20 Hrs [IST] The Goo ...
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...
San Diego, California Friday, April 4, 2025, 16:00 Hrs [IST] ...
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources: Dublin, Ireland Friday, April 4, 2025, 18:00 Hrs [IST] Biologit, a spec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results